Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/1995
08/08/1995US5439890 Erythromycin derivatives
08/08/1995US5439889 Erythromycin derivatives
08/08/1995US5439689 Diltiazem formulation
08/08/1995US5439687 Dosage forms having zero-order dihydropyridine calcium antagonist release
08/08/1995US5439685 Vaginal tampon containing cholic acid or salt as microbiocide, dimethylsiloxane as protective film forming agent, hydroxy-propylmethyl cellulose as thickener, benzalkonium chloride and nonoxynol 9 as spermicidal agents
08/08/1995US5439669 Biological imaging emulsions containing alkyl- or alkylglycerophosphoryl choline surfactants and methods of use
08/08/1995US5439570 Water soluble texaphyrin metal complexes for singlet oxygen production
08/08/1995CA2008108C Bis-aza-bicyclic anxiolytic agents
08/08/1995CA1336605C Indolylpiperidine compounds, processes for the preparation thereof and pharmaceutical composition comprising the same
08/08/1995CA1336601C Optical isomers
08/08/1995CA1336597C Azacycloalkane derivatives, absorption promoters containing the derivatives as the effective ingredient and external preparations containing the absorption promoters
08/08/1995CA1336581C Aloe composition and uses thereof
08/08/1995CA1336580C Compositions and methods for achieving improved physiological response to exercise
08/05/1995CA2141907A1 Virus msrvl and pathogen agent and/or msrv2 associated with multiple sclerosis, their nucleic constituants and their applications
08/05/1995CA2141782A1 Triazole derivatives having antimycotic activity
08/04/1995CA2141729A1 N-(3-aminopropyl)-n-phenyl-5,6,7,8-tetrahydro-naphthalene -2-carboxamide derivatives, their preparation and their therapeutic use
08/04/1995CA2141728A1 3-(2-aminoethyl)-4-¬3-(trifluoromethyl)benzoyl|-3, 4-dihydro-2h-1,4- benzoxazine derivatives, process for their preparation and their therapeutic application
08/04/1995CA2141645A1 Nasal spray compositions
08/03/1995WO1995020678A1 Human dna mismatch repair proteins
08/03/1995WO1995020661A1 Materials and methods for management of hyperacute rejection in human xenotransplantation
08/03/1995WO1995020660A2 Immunization by inoculation of dna transcription unit
08/03/1995WO1995020597A1 Modified oligonucleotides
08/03/1995WO1995020595A1 L-nucleosides for the treatment of hepatitis b-virus and epstein-bar virus
08/03/1995WO1995020588A1 Indole derivatives as 5-ht1 agonists
08/03/1995WO1995020587A1 Neuroprotective chroman compounds
08/03/1995WO1995020582A1 Δ12,13-iso-taxol analogs, antineoplastic use and pharmaceutical compositions containing them
08/03/1995WO1995020581A1 Novel human leukocyte elastase (hle) inhibitors, and related pharmaceutical compositions and methods of use
08/03/1995WO1995020579A1 Cyanoguanidines as k-channel blockers
08/03/1995WO1995020578A1 SUBSTITUTED AROMATIC COMPOUNDS AS c.AMP PHOSPHODIESTERASE- AND TNF-INHIBITORS
08/03/1995WO1995020576A1 4-(2-(3-aryloxy-2-hydroxypropylamino alkyloxy)-5-nitrophenyl)-1,4-dihydropyridines as antihypertensive agents
08/03/1995WO1995020575A1 Aralkylamino substituted azacyclic therapeutic agents
08/03/1995WO1995020571A1 A pharmaceutical product comprising a salicylate of an esterifiable ace-inhibitor
08/03/1995WO1995020568A1 Pharmaceutical product comprising a salicylate of an esterifiable beta-blocker
08/03/1995WO1995020567A1 Codrugs as a method of controlled drug delivery
08/03/1995WO1995020564A1 Leukotriene b4 derivatives, methods of preparing them and their use as drugs
08/03/1995WO1995020563A1 New leukotriene b4 derivatives, methods of preparing them and their use as drugs
08/03/1995WO1995020403A1 Aqueous topical compositions
08/03/1995WO1995020402A1 Antioxidants and intracellular glutathione raising agents for therapeutic treatments
08/03/1995WO1995020398A1 Human growth hormone
08/03/1995WO1995020396A1 Inhibitors of geranylgeranyl-protein transferase
08/03/1995WO1995020394A1 Oral dosage form containing colestipol as a carrier and acidic active substances and a process for producing the same
08/03/1995WO1995020393A1 Use of mometasone furoate for treating airway passage and lung diseases
08/03/1995WO1995020392A1 AGENT, INTENDED FOR TRANSDERMAL ADMINISTRATION, CONTAINING 14α,17α-ETHANOESTRA-1,3,5(10)-TRIENE-3,17β-DIOL
08/03/1995WO1995020391A1 Prostacyclin-containing oleaginous ointment
08/03/1995WO1995020390A1 Use of vanadium molybdenum or tungsten complexes for controlling cellular proliferation
08/03/1995WO1995020389A1 Benzoxazinones as inhibitors of hiv reverse transcriptase
08/03/1995WO1995020388A1 Anti-hiv drugs
08/03/1995WO1995020387A1 Method for preventing or reducing photosensitivity and/or phototoxicity reactions to medications
08/03/1995WO1995020386A1 7-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists
08/03/1995WO1995020385A1 Inhibition of arthritis by l-type calcium channel antagonists
08/03/1995WO1995020384A1 Pharmaceutical compositions containing hiv protease inhibitors
08/03/1995WO1995020383A1 Modified-release metronidazole compositions and methods for making and using same
08/03/1995WO1995020382A1 Process for producing s(+)-ibuprofen particles
08/03/1995WO1995020378A1 Compositions for treatment of glaucoma comprising pilocarpine and a beta-blocker
08/03/1995WO1995020375A1 Hair cosmetic composition
08/03/1995WO1995007918A3 Pyrimidine derivatives for labeled binding partners
08/03/1995WO1995004720A3 Gastrin and cck receptor ligands
08/03/1995DE4403769A1 Treating abnormal uterine bleeding in e.g. metrorrhagia
08/03/1995DE4402379A1 Orale Arzneiform mit sauren Wirkstoffen und Verfahren zu ihrer Herstellung Oral dosage form having acidic active ingredients, and processes for their preparation
08/03/1995DE19502566A1 N-Acetyl-Cystein-haltige pharmazeutische Zusammensetzungen N-acetyl-cysteine-containing pharmaceutical compositions
08/03/1995CA2540258A1 Pharmaceutical compositions containing hiv protease inhibitors
08/03/1995CA2182489A1 Antioxidants and intracellular glutathione raising agents for therapeutic treatments
08/03/1995CA2182219A1 Pharmaceutical product comprising a salicylate of an esterifiable beta-blocker
08/03/1995CA2182206A1 Human dna mismatch repair proteins
08/03/1995CA2182205A1 Human growth hormone
08/03/1995CA2182203A1 Novel human leukocyte elastase (hle) inhibitors, and related pharmaceutical compositions and methods of use
08/03/1995CA2182198A1 A pharmaceutical product comprising a salicylate of an esterifiable ace-inhibitor
08/03/1995CA2182191A1 New leukotriene b4 derivatives, methods of preparing them and their use as drugs
08/03/1995CA2182188A1 Agent, intended for transdermal administration, containing 14.alpha.,17.alpha.-ethanoestra-1,3,5(10)-triene-3,17.beta.-diol
08/03/1995CA2182114A1 Inhibition of arthritis by l-type calcium channel antagonists
08/03/1995CA2181475A1 Indole derivatives as 5-ht1 agonists
08/03/1995CA2181376A1 Aralkylamino substituted azacyclic therapeutic agents
08/03/1995CA2180732A1 Anti-hiv drugs
08/03/1995CA2180727A1 Modified oligonucleotides
08/03/1995CA2180528A1 Inhibitors of geranylgeranyl-protein transferase
08/03/1995CA2179715A1 Use of vanadium molybdenum or tungsten complexes for controlling cellular proliferation
08/03/1995CA2179176A1 .delta.12,13-iso-taxol analogs, antineoplastic use and pharmaceutical compositions containing them
08/03/1995CA2179036A1 Cyanoguanidines as k-channel blockers
08/03/1995CA2159224A1 Prostacyclin-containing oleaginous ointment
08/02/1995EP0665289A2 Peptides from GAD65, provoking autoimmune reactions
08/02/1995EP0665245A1 Preparation of crosslinked anion exchange particles
08/02/1995EP0665238A1 Corticoid derivatives and pharmaceutical and cosmetic compositions
08/02/1995EP0665228A1 Pharmaceutical compositions containing 3-phenylsulfonyl-3,7-diazabicyclo 3,3,1 nonanes
08/02/1995EP0665227A1 Polyhydronorharman synthase inhibitors
08/02/1995EP0665223A1 Antitumor agent, novel 3(2H)-pyridazinone derivatives and their preparation
08/02/1995EP0665215A1 1,4-Diamino-2,3-dihydroxybutanes
08/02/1995EP0665020A2 Method for preparing thioether conjugates
08/02/1995EP0665015A2 Combination treatment for osteoporosis
08/02/1995EP0665014A1 3-benzoyl-3,7-diazabicyclo(3,3,1)nonane anti-arrhythmic compounds
08/02/1995EP0665013A1 Method of treating hyperproliferative vascular disease
08/02/1995EP0665012A1 Antiallergy agent and nutritional composition containing glutamine and process for the production thereof
08/02/1995EP0665011A1 Parasiticide against endoparasites comprising a pyrethroid type compound
08/02/1995EP0665003A1 The use of a spin acceptor in a cosmetic on dermatological composition
08/02/1995EP0664819A1 Chelating polymers.
08/02/1995EP0664811A1 Gestagenically active 19,11-bridged 4-estrenes.
08/02/1995EP0664810A1 3,3-disubstituted tri- and tetracyclic indolin-2-ones useful for the treatment of cognitive disorders
08/02/1995EP0664808A1 Imidazopyridine derivatives as 5-ht 4? receptor antagonists
08/02/1995EP0664806A1 Heterocyclic condensed benzoic acid derivatives as 5-ht 4? receptor antagonists
08/02/1995EP0664805A1 Heterocyclic -esters or -amides used as 5-ht 4? receptor antagonists
08/02/1995EP0664804A1 Benzofuran derivatives as 5-ht1-like receptor antagonists
1 ... 6996 6997 6998 6999 7000 7001 7002 7003 7004 7005 7006 7007 7008 7009 7010 7011 7012 7013 7014 7015 7016 ... 7860